Display options
Cite
de Sio I, Iadevaia MD, Vitale LM, et al. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European Gastroenterol J. 2014;2(4):279-87doi: 10.1177/2050640614538964.
de Sio, I., Iadevaia, M. D., Vitale, L. M., Niosi, M., Del Prete, A., de Sio, C., Romano, L., Funaro, A., Meucci, R., Federico, A., Loguercio, C., & Romano, M. (2014). Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European gastroenterology journal, 2(4), 279-87. https://doi.org/10.1177/2050640614538964
de Sio, Ilario, et al. "Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study." United European gastroenterology journal vol. 2,4 (2014): 279-87. doi: https://doi.org/10.1177/2050640614538964
de Sio I, Iadevaia MD, Vitale LM, Niosi M, Del Prete A, de Sio C, Romano L, Funaro A, Meucci R, Federico A, Loguercio C, Romano M. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study. United European Gastroenterol J. 2014 Aug;2(4):279-87. doi: 10.1177/2050640614538964. PMID: 25083285; PMCID: PMC4114116.
Copy Download .nbib Format: NLM
Share it on

United European Gastroenterol J. 2014 Aug;2(4):279-87. doi: 10.1177/2050640614538964.

Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.

United European gastroenterology journal

Ilario de Sio, Maddalena D Iadevaia, Luigi M Vitale, Marco Niosi, Anna Del Prete, Chiara de Sio, Lorenzo Romano, Annalisa Funaro, Rosaria Meucci, Alessandro Federico, Carmelina Loguercio, Marco Romano

Affiliations

  1. Department of Clinical and Experimental Medicine 'Magrassi-Lanzara', Second University of Naples, Naples, Italy.

PMID: 25083285 PMCID: PMC4114116 DOI: 10.1177/2050640614538964

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of death amongst cirrhotic patients. Its diagnosis and discrimination from non-HCC malignant lesions in cirrhosis includes contrast enhanced computed tomography (CECT), contrast enhanced magnetic resonance imaging (CEMRI), or, in selected cases, liver biopsy. The role of contrast-enhanced ultrasonography (CEUS) is still controversial.

AIMS: To evaluate whether, by selecting an appropriate 'time to wash-out' cut-off value, CEUS capability of discriminating between HCC and non-HCC malignancies in cirrhotic patients may be enhanced.

METHODS: We enrolled 282 cirrhotic patients who underwent CEUS at our institute, from January 2008 to January 2012, for focal liver lesions (FLLs) detected at ultrasound (US). We used liver biopsy and subsequent histological evaluation as the gold standard for correct classification of FLLs. We calculated the area under receiver operator characteristic curves for CEUS to distinguish patients with HCC from those with non-HCC malignancies. The best 'time to wash-out' cut-off values were selected.

RESULTS: HISTOLOGICAL DIAGNOSIS OF FLLS WAS AS FOLLOWS: 34 benign lesions (i.e. 25 regenerative nodules and 9 dysplastic nodules) and 248 malignant lesions (223 well-to-moderately differentiated HCCs; 7 poorly-differentiated HCCs; 5 intrahepatic colangiocellular carcinomas (ICCs); 5 primary non-Hodgkin B-cell lymphomas (NHBLs); and 8 metastatic liver tumors). A time to wash-out > 55 s identified patients with HCC with the highest level of accuracy (92.7%). Similarly, a time to wash-out ≤ 55 s correctly identified the vast majority of the non-HCC malignancies (100% sensitivity, 98.2% specificity and diagnostic accuracy of 98.3%).

CONCLUSIONS: CEUS is an accurate and safe procedure for discriminating FLLs in cirrhotic patients, especially when a cut-off time to wash-out of 55 s is chosen as a reference value.

Keywords: Biopsy; cholangiocellular carcinoma; cirrhosis; contrast enhancement; focal liver lesions; hepatocellular carcinoma; liver; ultrasound

References

  1. Dig Dis. 2011;29(3):339-64 - PubMed
  2. Dig Liver Dis. 2007 Feb;39(2):187-95 - PubMed
  3. Hepatology. 2010 Jun;51(6):2020-9 - PubMed
  4. Ultraschall Med. 2008 Oct;29(5):499-505 - PubMed
  5. Ultraschall Med. 2008 Feb;29(1):28-44 - PubMed
  6. Ultraschall Med. 2012 Jul;33 Suppl 1:S57-66 - PubMed
  7. Clin Ter. 2001 May-Jun;152(3):185-8 - PubMed
  8. Hepatology. 2011 Mar;53(3):1020-2 - PubMed
  9. J Hepatol. 2001 Sep;35(3):421-30 - PubMed
  10. Invest Radiol. 2001 Feb;36(2):104-9 - PubMed
  11. Ultraschall Med. 2009 Jun;30(3):259-68 - PubMed
  12. Dig Liver Dis. 2013 Oct;45(10):816-9 - PubMed
  13. Hepatol Int. 2010 Mar 18;4(2):439-74 - PubMed
  14. Ultrasound Med Biol. 2006 Sep;32(9):1369-75 - PubMed
  15. Dig Liver Dis. 2013 Sep;45(9):712-23 - PubMed
  16. Am J Gastroenterol. 2002 Feb;97(2):397-405 - PubMed
  17. Ultraschall Med. 2013 Feb;34(1):11-29 - PubMed
  18. J Radiol. 2009 Jan;90(1 Pt 2):109-22 - PubMed
  19. Cancer. 1954 May;7(3):462-503 - PubMed
  20. AJR Am J Roentgenol. 1995 May;164(5):1131-5 - PubMed
  21. Aliment Pharmacol Ther. 2009 Jul;30(1):37-47 - PubMed
  22. J Hepatol. 2012 Apr;56(4):908-43 - PubMed
  23. Abdom Imaging. 2004 Sep-Oct;29(5):540-7 - PubMed
  24. Med Ultrason. 2010 Dec;12(4):280-5 - PubMed
  25. Eur Radiol. 2010 Mar;20(3):743-53 - PubMed
  26. J Hepatol. 2008;48 Suppl 1:S20-37 - PubMed
  27. Gut. 2004 Sep;53(9):1356-62 - PubMed
  28. Ultraschall Med. 2012 Jul;33 Suppl 1:S48-56 - PubMed
  29. J Clin Ultrasound. 2010 Jan;38(1):1-9 - PubMed
  30. Dig Liver Dis. 2011 Jun;43(6):484-90 - PubMed
  31. Eur Radiol. 2004 Jun;14(6):1092-9 - PubMed
  32. Ultraschall Med. 2009 Aug;30(4):329-32 - PubMed
  33. J Hepatol. 2010 Aug;53(2):291-7 - PubMed
  34. Hepatology. 2002 Mar;35(3):519-24 - PubMed
  35. Semin Roentgenol. 2009 Oct;44(4):266-82 - PubMed

Publication Types